Lifeward Ltd. plans to list on the Nasdaq under the symbol LFWD, offering 4,000,000 ordinary shares. It filed a Form S-1 registration statement for an initial public offering on February 11, 2025. As of November 6, 2026, its final prospectus is on file (Form 424B4, June 26, 2025).
Sell to companies like Lifeward Ltd? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
Lifeward Ltd. filed a Form S-1 registration statement for an initial public offering on 2025-02-11. It has amended it 2 times. It filed its final prospectus on 2025-06-26. Each fact below is quoted from the filing named with it.
Also on the record for Lifeward Ltd.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| October 27, 2026 | Leadership change: Ronen Tsimerman appointed, Chief Financial Officer | — | Leadership changes | Source |
| October 1, 2026 | Leadership change: Josh Hexter appointed, Chief Executive Officer | — | Leadership changes | Source |
| August 31, 2026 | Leadership change: Mark Grant departs, President and Chief Executive Officer, and 1 more | — | Leadership changes | Source |
| August 20, 2026 | Leadership change: Yonason Greenwald appointed, and 2 more | — | Leadership changes | Source |
| August 14, 2026 | Leadership change: Almog Adar departs, Chief Financial Officer | — | Leadership changes | Source |
| July 8, 2026 | Form D, private offering | $11.16M sold | Form D page | Source |
| May 14, 2026 | Stake report, Schedule 13D, by Oramed Pharmaceuticals Inc. | 49.9% of the class | 5%+ stakes | Source |
| April 23, 2026 | Leadership change filing (Form 8-K, Item 5.02) | — | Leadership changes | Source |
| April 2, 2026 | Form D, private offering | $20M sold | Form D page | Source |
| March 25, 2026 | Acquired Oratech Ltd. | — | Acquisition | Source |
| July 1, 2025 | Stake report, Schedule 13G, by Mitchell P. Kopin | 4.99% of the class | 5%+ stakes | Source |
| January 13, 2025 | Form D, private offering | $5M sold | Form D page | Source |
Check before you invest in Lifeward Ltd.: the warning signs and who's behind it, free.
Free to see. No signup.
Keep reading
More on Lifeward Ltd. and the records around it.
Lifeward Ltd. elsewhere on the record
- Leadership changes Aug 2026
- Company profile and every filing Jul 2026
- Form D filing Jul 2026
- 5%+ stake filings May 2026
- Form D filing Apr 2026
- Acquisition Mar 2026
- Who owns it
Companies that share a holder
- Oramed Pharmaceuticals Inc. also filed stake reports on 2 other companies: Nano Dimension Ltd. (Jul 2026), Scilex Holding Co (Feb 2026)
- Mitchell P. Kopin also filed stake reports on 55 other companies: SCWorx Corp. (Sep 2026), NFT Limited (Aug 2026), Silexion Therapeutics Corp (Aug 2026)
Also filing to list on the Nasdaq
IPO filings on the Nasdaq in Q2 2025, newest first.
- Safe Pro Group Inc. (Jun 2025)
- Antalpha Platform Holding Co (May 2025)
Watch Lifeward Ltd.
Get an email when Lifeward Ltd. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Lifeward Ltd.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Lifeward Ltd.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Lifeward Ltd. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
17 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
What the filings say
Listing
Our ordinary shares are listed on Nasdaq under the symbol “LFWD.”From the 424B4 filed 2025-06-26
Shares offered
We are offering 4,000,000 ordinary shares, par value NIS 1.75 per share, together with warrants to purchase up to 4,000,000 ordinary shares (the “Warrants”), pursuant to this prospectus.From the 424B4 filed 2025-06-26
Use of proceeds
We currently intend to use the net proceeds from this offering for continuing commercial efforts, working capital, and general corporate purposes.From the 424B4 filed 2025-06-26
Revenue
For the year ended December 31, 2023, we recorded revenue of approximately $13.9 million.From the S-1/A filed 2025-02-14
Timeline
| Filed | What it is | Filing |
|---|---|---|
| 2025-02-11 | Registration statement filed | S-1 |
| 2025-02-14 | Registration statement amended | S-1/A |
| 2025-06-20 | Registration statement filed | S-1 |
| 2025-06-25 | Registration statement amended | S-1/A |
| 2025-06-26 | Final prospectus filed: the offering is priced | 424B4 |
Lifeward Ltd.'s full funding historyFounders and team
Tools for this story
Each opens in a new tab, filled in for Lifeward Ltd.. With no account yet, you sign up free and land on the result.
Where this comes from
A company that wants to sell shares to the public in the United States files a registration statement with the SEC: Form S-1 for a US company, Form F-1 for a foreign one. It amends that statement as the figures and terms are filled in, usually adding the expected price range shortly before the offering. Once the offering is priced it files its final prospectus under Rule 424(b)(4). A company that decides not to go ahead can ask for the registration statement to be withdrawn on Form RW.
Every row on this page is one of those filings, linked to the filing itself. The facts are the company's own sentences, quoted from the filing named beside each one and never reworded; where no filing states a fact in a sentence that can be read exactly, this page leaves it out. A filing is the company's statement of its plans and its figures, not a verification of them, and nothing here is investment advice.